Publications
-
Intravenous immunoglobulin products contain specific antibodies to recombinant human tau protein.
Int Immunopharmacol.; doi: 10.1016/j.intimp.2013.04.034.
Lynnae M.Smith, Mary P.Coffey, Andrea C.Klaver, David A.Loeffler (2012) -
Leucine Carboxyl Methyltransferase 1 (LCMT1)-dependent Methylation Regulates the Association of Protein Phosphatase 2A and Tau Protein with Plasma Membrane Microdomains in Neuroblastoma Cells.
The Journal of Biological Chemistry; doi: 10.1074/jbc.M113.490102.
Jean-Marie Sontag, Viyada Nunbhakdi-Craig, and Estelle Sontag (2012) -
The CAMKK2-AMPK Kinase Pathway Mediates the Synaptotoxic Effects of Ab Oligomers through Tau Phosphorylation.
Cell Press; .
Georges Mairet-Coello, Julien Courchet, Simon Pieraut, Virginie Courchet, Anton Maximov, and Franck Polleux (2012) -
Molecular Mechanism of Tau Aggregation Induced by Anionic and Cationic Dyes.
IOS Press; DOI: 10.3233/JAD-121765 (Pay to View).
Karla I. Lira-De León, Ponciano García-Gutiérrez, Iris N. Serratos, Marianela Palomera-Cárdenas, María del P. Figueroa-Corona, Victoria Campos-Peña, Marco A. Meraz-Ríos (2012) -
Immunotherapy targeting tau pathology-studies in an hTau mouse model.
umi.com; Publication Number 3535073.
Stefanie Karen Forest (2012) -
Molecular Mechanism of Tau Aggregation Induced by Anionic and Cationic Dyes.
IOS Press; DOI 10.3233/JAD-121765.
Karla I. Lira-De Leo ́n, Ponciano Garc ́ıa-Gutie ́rrez,Iris N. Serratos, Marianela Palomera-Ca ́rdenas, Mar ́ıa del P. Figueroa-Corona, Victoria Campos-Pen ̃a, Marco A. Meraz-R ́ıos (2012) -
Sensitive quantitative assays for tau and phospho-tau in transgenic mouse models.
Elsevier Inc.; doi:10.1016/j.neurobiolaging.2012.05.010.
Christopher M. Acker, Stefanie K. Forest, Ray Zinkowski, Peter Davies, Cristina d'Abramo (2012) -
Effects of intravenous immunoglobulin on alpha synuclein aggregation and neurotoxicity.
Int Immunopharmacol; 2012 Sep 28. pii: S1567-5769(12)00270-6. doi: 10.1016/j.intimp.2012.09.007..
Smith LM, Klaver AC, Coffey MP, Dang L, Loeffler DA. (2011) -
https://www.ncbi.nlm.nih.gov/pubmed/22843695. Novel one-step immunoassays to quantify α-synuclein: applications for biomarker development and high-throughput screening.
J Biol Chem.; DOI: 10.1074/jbc.M112.379792.
Michael Bidinosti, Derya R. Shimshek, Brit Mollenhauer, David Marcellin, Tatjana Schweizer, Gregor P. Lotz, Michael G. Schlossmacher, Andreas Weiss (2011) -
Lowered Serum Amyloid-β1-42 Autoantibodies in Individuals with Lifetime Depression.
Journal of Alzheimer’s Disease; 2012 Jul 5. [Epub ahead of print] DOI: 10.3233/JAD-2012-120625.
Maetzler W, Langkamp M, Lerche S, Godau J, Brockmann K, Gaenslen A, Huber H, Wurster I, Niebler R, Eschweiler GW, Berg D. (2011) -
Methamphetamine binds to α-synuclein and causes a conformational change which can be detected by nanopore analysis.
FEBS Letters; In Press, Uncorrected proof (5 July 2012), doi:10.1016/j.febslet.2012.06.040.
Tavassoly, O., Lee, J.S. (2011) -
A Novel “Molecular Tweezer” Inhibitor of α-Synuclein Neurotoxicity in Vitro and in Vivo.
Neurotherapeutics; Volume 9, Number 2, 464-476, DOI: 10.1007/s13311-012-0105-1.
Prabhudesai, S., Sinha, S., Attar, A., Kotagiri, A., Fitzmaurice, AG, Lakshmanan, R., Ivanova, MI, Loo, JA, Klärner, FG and Schrader, T., et al. (2011) -
New evidence on α-synuclein and Tau binding to conformation and sequence specific GC* rich DNA: Relevance to neurological disorders.
J Pharm Bioallied Sci.; 2012 Apr-Jun; 4(2): 112–117. doi: 10.4103/0975-7406.9481; PMCID: PMC3341714.
Vasudevaraju, P., Guerrero, E., Hegde, ML, Collen, TB, Britton, GB, and Rao, KS (2011) -
An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology.
Acta Neuropathologica; 2012, DOI: 10.1007/s00401-012-0964-x.
Kovacs, GG, Wagner, U., Dumont, B., Pikkarainen, M., Osman, AA, Streichenberger, N., Leisser, I., Verchère, J., Baron, T. and Alafuzoff, I., et al. (2011) -
α-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases..
Journal of Neurochemistry; 120: 440–452. 2012 Feb; doi: 10.1111/j.1471-4159.2011.07576.x.
Martin, Z. S., Neugebauer, V., Dineley, K. T., Kayed, R., Zhang, W., Reese, L. C. and Taglialatela, G., (2011) -
α-Synuclein potentiates interleukin-1β-induced CXCL10 expression in human A172 astrocytoma cells.
Neuroscience Letters; Volume 507, Issue 2, 24 January 2012, Pages 133–136 DOI /10.1016/j.neulet.2011.12.001.
Tousi, A.S., Buck, D.J., Curtis, T., Davis, R.L. (2011) -
A Selected Reaction Monitoring (SRM)-Based Method for Absolute Quantification of A 38, A 40, and A 42 in Cerebrospinal Fluid of Alzheimer’s Disease Patients and Healthy Controls.
IOS Press; DOI: 10.3233/JAD-2012-121471.
Josef Pannee, Erik Portelius, Madalina Oppermann, Alan Atkins, Martin Hornshaw, Ingrid Zegers, Peter Höjrup, Lennart Minthon, Oskar Hansson, Henrik Zetterberg, Kaj Blennow, Johan Gobom (2011) -
Methods for Measuring Tau Pathology in Transgenic Mouse Models.
IOS Press; DOI 10.3233/JAD-2012-121354, PMID: 22976073 (Pay to View).
Forest SK, Acker CM, d'Abramo C, Davies P. (2011) -
Development and assessment of sensitive immuno‐PCR assays for the quantification of cerebrospinal fluid three‐ and four‐repeat tau isoforms in tauopathies.
Journal of Neurochemistry; https://doi.org/10.1111/j.1471-4159.2012.07911.x.
Connie Luk, Yaroslau Compta, Nadia Magdalinou, Maria José Martí, Geshanthi Hondhamuni, Henrik Zetterberg, Kaj Blennow, Radu Constantinescu, Yolande Pijnenburg (2011) -
Constitutive secretion of tau protein by an unconventional mechanism.
Neurobiology of Disease; Available online 2 June 2012 DOI 10.1016/j.nbd.2012.05.021.
Chai, X., Dage, J.L., Citron, M. (2011)
